LakeShore Biopharma (LSB) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
LakeShore Biopharma announced the resignation of its head of marketing and sales, Mr. Gang Li, effective November 30, 2024, due to personal reasons. The company has appointed Ms. Zhiyuan Ran, who has extensive experience in marketing vaccine products, to assume his responsibilities. This leadership transition highlights LakeShore Biopharma’s commitment to ensuring continuity and expertise in its marketing and sales operations.
For further insights into LSB stock, check out TipRanks’ Stock Analysis page.
